102 related articles for article (PubMed ID: 27531787)
61. [Correlation of serum ADAMTS13 and TSP1 levels with myocardial injury and prognosis in patients with acute coronary syndrome].
Yao Z; Bao B; Qian S; Li Z; Lu Q; Min S; Li M; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):710-715. PubMed ID: 34134958
[TBL] [Abstract][Full Text] [Related]
62. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure.
Gombos T; Makó V; Cervenak L; Papassotiriou J; Kunde J; Hársfalvi J; Förhécz Z; Pozsonyi Z; Borgulya G; Jánoskuti L; Prohászka Z
Thromb Haemost; 2009 Sep; 102(3):573-80. PubMed ID: 19718479
[TBL] [Abstract][Full Text] [Related]
63. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
64. Changes in von Willebrand factor and ADAMTS13 during IVF.
Westerlund E; Antovic A; Hovatta O; Eberg KP; Blombäck M; Wallén H; Henriksson P
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):127-31. PubMed ID: 21192251
[TBL] [Abstract][Full Text] [Related]
65. Increased prothrombotic property as a risk factor of acute kidney injury after surgical repair of abdominal aortic aneurysm: a prospective observational study.
Innami Y; Katori N; Mori K; Kosugi S; Suzuki T; Sakurai N; Nagata H; Takeda J; Morisaki H
J Intensive Care; 2014; 2():46. PubMed ID: 25960882
[TBL] [Abstract][Full Text] [Related]
66. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
[TBL] [Abstract][Full Text] [Related]
67. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
Löwenberg EC; Charunwatthana P; Cohen S; van den Born BJ; Meijers JC; Yunus EB; Hassan MU; Hoque G; Maude RJ; Nuchsongsin F; Levi M; Dondorp AM
Thromb Haemost; 2010 Jan; 103(1):181-7. PubMed ID: 20062916
[TBL] [Abstract][Full Text] [Related]
68. Thrombosis and von Willebrand Factor.
Shahidi M
Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
[TBL] [Abstract][Full Text] [Related]
69. ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia.
Alpoim PN; Gomes KB; Godoi LC; Rios DR; Carvalho MG; Fernandes AP; Dusse LM
Clin Chim Acta; 2011 Nov; 412(23-24):2162-6. PubMed ID: 21840304
[TBL] [Abstract][Full Text] [Related]
70. Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease.
Denorme F; Kraft P; Pareyn I; Drechsler C; Deckmyn H; Vanhoorelbeke K; Kleinschnitz C; De Meyer SF
PLoS One; 2017; 12(6):e0179258. PubMed ID: 28591212
[TBL] [Abstract][Full Text] [Related]
71. Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients.
Wójcik K; Bazan-Socha S; Celejewska-Wójcik N; Górka K; Lichołai S; Polok K; Stachura T; Zaręba L; Dziedzic R; Gradzikiewicz A; Sanak M; Musiał J; Sładek K; Iwaniec T
Thromb Res; 2023 Mar; 223():80-86. PubMed ID: 36709678
[TBL] [Abstract][Full Text] [Related]
72. Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus.
Penglong T; Boontanvansom A; Viboonjuntra P; Siripaitoon B
Blood Coagul Fibrinolysis; 2023 Oct; 34(7):432-438. PubMed ID: 37577878
[TBL] [Abstract][Full Text] [Related]
73. REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS.
Madarati H; Singh K; Sparring T; Andrisani P; Liaw PC; Fox-Robichaud AE; Kretz CA
Shock; 2024 Feb; 61(2):189-196. PubMed ID: 38150358
[TBL] [Abstract][Full Text] [Related]
74. In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease.
Katneni UK; Holcomb DD; Hernandez NE; Hamasaki-Katagiri N; Hunt RC; Bar H; Ibla JC; Kimchi-Sarfaty C
Thromb Res; 2020 Sep; 193():66-76. PubMed ID: 32531546
[TBL] [Abstract][Full Text] [Related]
75. [New progress in clinical significance of ADAMTS13].
Shi HP; Wang ZY
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):903-906. PubMed ID: 29166749
[No Abstract] [Full Text] [Related]
76. Pro-Inflammatory and Prothrombotic Factors and Metabolic Syndrome.
Sypniewska G
EJIFCC; 2007 Feb; 18(1):39-46. PubMed ID: 29632466
[No Abstract] [Full Text] [Related]
77. Impact of renal impairment on platelet reactivity and clinical outcomes during chronic dual antiplatelet therapy following coronary stenting.
Guo LZ; Kim MH; Shim CH; Choi SY; Serebruany VL
Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):145-51. PubMed ID: 27533756
[TBL] [Abstract][Full Text] [Related]
78. [ADAMTS13 Level in Prothrombotic Status and Its Related Factor Analysis].
Sun CF; Liu GQ; Zhao X; Han F; Xu M; Xing J; Liu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1125-31. PubMed ID: 27531787
[TBL] [Abstract][Full Text] [Related]
79. [Changes of ADAMTS13 Activity and TSP1 Level in Patients with Hematologic Malignancies].
Sun CF; Zhao X; Han F; Jia Q; Wang L; Lu G; Ding HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1294-1298. PubMed ID: 27784345
[TBL] [Abstract][Full Text] [Related]
80. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
